AJP - Heart AJP: Cell Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 280: H2076-H2086, 2001;
0363-6135/01 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (31)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Migliavacca, F.
Right arrow Articles by de Leval, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Migliavacca, F.
Right arrow Articles by de Leval, M. R.
Vol. 280, Issue 5, H2076-H2086, May 2001

Modeling of the Norwood circulation: effects of shunt size, vascular resistances, and heart rate

Francesco Migliavacca1, Giancarlo Pennati2, Gabriele Dubini3, Roberto Fumero2, Riccardo Pietrabissa2, Gonzalo Urcelay4, Edward L. Bove4, Tain-Yen Hsia1, and Marc R. de Leval1

1 Cardiothoracic Unit, Great Ormond Street Hospital for Children, WC1N 3JH London, United Kingdom; 2 Bioengineering and 3 Energy Engineering Departments and Laboratory of Biological Structure Mechanics, Politecnico di Milano, 20133 Milan, Italy; and 4 Pediatric Cardiovascular Surgery, The University of Michigan Health System, Ann Arbor, Michigan 48109


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Hypoplastic left heart syndrome is the most common lethal cardiac malformation of the newborn. Its treatment, apart from heart transplantation, is the Norwood operation. The initial procedure for this staged repair consists of reconstructing a circulation where a single outlet from the heart provides systemic perfusion and an interpositioning shunt contributes blood flow to the lungs. To better understand this unique physiology, a computational model of the Norwood circulation was constructed on the basis of compartmental analysis. Influences of shunt diameter, systemic and pulmonary vascular resistance, and heart rate on the cardiovascular dynamics and oxygenation were studied. Simulations showed that 1) larger shunts diverted an increased proportion of cardiac output to the lungs, away from systemic perfusion, resulting in poorer O2 delivery, 2) systemic vascular resistance exerted more effect on hemodynamics than pulmonary vascular resistance, 3) systemic arterial oxygenation was minimally influenced by heart rate changes, 4) there was a better correlation between venous O2 saturation and O2 delivery than between arterial O2 saturation and O2 delivery, and 5) a pulmonary-to-systemic blood flow ratio of 1 resulted in optimal O2 delivery in all physiological states and shunt sizes.

congenital heart disease; computer model; hypoplastic left heart syndrome


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

HYPOPLASTIC LEFT HEART SYNDROME is a lethal condition characterized by a hypoplasia of the left ventricle, the mitral valve, the aortic valve, and the ascending aorta. Preoperative survival relies on the patency of the ductus arteriosus to supply the systemic circulation. The initial operation (Norwood stage I, Fig. 1) consists in using the pulmonary valve and the main pulmonary artery as the systemic outflow and interposing a shunt between the innominate artery and the right pulmonary artery as a source of pulmonary blood flow (5, 11). Despite improved prognosis with the introduction and refinement of the palliative Norwood operation, immediate postoperative mortality remains at 20-30%, even in high-volume centers (4). During the second stage of the operation, the pulmonary flow from the shunt is replaced by a superior vena cava-to-pulmonary arterial anastomosis, and the final stage consists in connecting the inferior vena cava to the pulmonary artery (total cavopulmonary connection).


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 1.   Anatomic sketch of the Norwood operation stage I. IA, innominate artery; LPA, left pulmonary artery; LCA, left carotid artery; RPA, right pulmonary artery; RSA, right subclavian artery; LSA, left subclavian artery; CCA, common carotid artery; neoaorta, reconstructed systemic outflow made of the pulmonary valve and the main pulmonary artery. Gray areas represent prosthetic patch and shunt.

After the first-stage reconstruction, the systemic and pulmonary circulations are in parallel, and the right ventricle acts as the sole hydraulic power source. The distribution of the cardiac output between the systemic and the pulmonary circulations is governed in part by the interposition shunt. Various pharmacological and therapeutic interventions in the early postoperative period are aimed at maintaining this delicate balance between the two circulations (3, 11).

We have developed a lumped-parameter model of the Norwood circulation to study the cardiovascular effects of changes in geometry of the interposition shunt, systemic and pulmonary vascular resistance, and heart rate.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Mathematical Model

A lumped-parameter model of the Norwood circulation was built following the methodology previously used to model the fetal (2, 12) and neonatal circulation (14, 15). The model is made of three subsystems: the hypoplastic heart, the systemic circulation, and the pulmonary circulation (Fig. 2).


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 2.   A: hydraulic network of the model with the systemic-to-pulmonary shunt represented. Arrows indicate the normal direction of flow. Values of the shunt parameters are evaluated from 3-dimensional mathematical models of the connection. QP and QS, pulmonary and systemic blood flow; CO, cardiac output; ASD, atrial septal defect; DA, descending aorta; LA, left atrium; Neoao, aortic valve; PAB, pulmonary arterial bed; PA, proximal pulmonary arteries; PVB, pulmonary venous bed; RA, right atrium; SAB, systemic arterial bed; SVB, systemic venous bed; SV, single ventricle; SLV, systemic large veins; Tric, tricuspid valve. See MATERIALS AND METHODS for description of electrical equivalents. B: activation (A) functions for LA, RA, and SV. Tc, cardiac cycle duration; Ts, duration of systole.

Heart. Models for both atria [left (LA) and right (RA)] and the single ventricle (SV) are mathematically similar; differences are reflected by defining appropriate values of the various parameters within each model.

Pressure within any cardiac chamber (Pcc) varies throughout the cardiac cycle because of changes of volume within the chamber (Vcc) and contractile activity of the sarcomeres. Active (systolic) and passive (diastolic) properties of the myocardium account for the total chamber pressure (Pcc). This can be expressed mathematically as (27)
P<SUB>cc</SUB>(<IT>t</IT>)<IT>=</IT>P<SUB>cc,active</SUB>(<IT>t, </IT>V<SUB>cc</SUB>)<IT>+</IT>P<SUB>cc,passive</SUB>(<IT>t, </IT>V<SUB>cc</SUB>) cc<IT>=</IT>SV, RA, LA
Active and passive pressure-volume relationships are nonlinear (26), despite the usual practice of approximating the active curve as a straight line (28). The active relationship changes during systole as contractile activity of the cardiac chamber changes. Furthermore, the slope [i.e., the elastance (E)] of the active curve decreases with increasing volume. We mimicked this behavior as a time-varying elastance Ecc[Vcc(t)] that depends also on chamber volume. This elastance, which accounts for the isometric pressure-volume function, was coupled with a constant viscous term, Rwall, that is related to the dissipative properties of the myocardium
P<SUB>cc,active</SUB>(<IT>t</IT>)<IT>=E</IT><SUB>cc</SUB>(V<SUB>cc</SUB>, <IT>t</IT>)<IT> · </IT>[V<SUB>cc</SUB>(<IT>t</IT>)<IT>−</IT>V<SUB>u,cc</SUB>]<IT>+R</IT><SUB>wall,cc</SUB><IT> · </IT><FR><NU>dV<SUB>cc</SUB>(<IT>t</IT>)</NU><DE>d<IT>t</IT></DE></FR>
where Vu,cc is the unstressed volume of the cardiac chamber (i.e., the volume at zero pressure). The viscous term was considered only for the ventricle (1).

Elastance can be expressed as a product of a pulsatile activation time function [Acc(t)] and a purely volume elastance term [E*cc(Vcc)]
E<SUB>cc</SUB>(V<SUB>cc</SUB>, <IT>t</IT>)<IT>=A</IT><SUB>cc</SUB>(<IT>t</IT>)<IT> · E</IT><SUP>*</SUP><SUB>cc</SUB>(V<SUB>cc</SUB>)
Ranging between 0 during the diastole and 1 at the end of systole as a squared sinusoidal function, Acc(t) describes the excitation-relaxation pattern of the myocardiac sarcomeres (1, 28). The activation function has the same form for the single ventricle and the atria and RA but has different initiation (Delta T) and temporal lapse (Fig. 2). The expression of E*cc(Vcc) depends on the pressure-volume relationship during systole of the cardiac chamber. For both atria, we assumed a linear pressure-volume function so that E*RA(VRA) and E*LA(VLA) are constant. For the single ventricle, a second-order polynomial function is adopted where the elastance decreases linearly with increasing volume
E<SUP>*</SUP><SUB>SV</SUB>(V<SUB>SV</SUB>)<IT>=E</IT><SUP>*</SUP><SUB>1,SV</SUB><IT>+E</IT><SUP>*</SUP><SUB>2,SV</SUB><IT> · </IT>(V<SUB>SV</SUB><IT>−</IT>V<SUB>u,SV</SUB>)
At diastole, when the muscle fibers are relaxed, the single ventricle and the atria fill through an exponential pressure-volume function (25, 28), reflecting the nonlinear elasticity of the relaxed muscle and pericardium
P<SUB>cc,passive</SUB>(<IT>t</IT>)<IT>=</IT>P<SUB>0,cc</SUB><IT> · </IT>{<IT>e</IT><SUP><IT>K</IT><SUB><IT>E,</IT>cc</SUB>[V<SUB>cc</SUB>(<IT>t</IT>)<IT>−</IT>V<SUB>cc,u</SUB>]</SUP><IT>−1</IT>}
where P0,cc and KE,cc are constant parameters.

Atrioventricular [tricuspid (Tric)] and ventriculoarterial [neoaorta (Neoao)] valves were mimicked as a series of an ideal unidirectional valve and resistance. Flows through these valves were described by a nonlinear relationship between the pressure drop [Delta P(t)] and the volume flow rate [Q(t)] across them
&Dgr;P<SUB>valv</SUB>(<IT>t</IT>)<IT>=K</IT><SUB>valv</SUB><IT> · </IT><A><AC>Q</AC><AC>˙</AC></A>(<IT>t</IT>)<SUP><IT>2</IT></SUP> valv<IT>=</IT>Tric, Neoao
Finally, the nonrestrictive atrial septal defect (ASD) that allows flow from the left into the right atrium was simulated as a constant resistance (RASD).

Vascular system. The vascular circulation was divided into two subsystems connected by the systemic-to-pulmonary shunt. The systemic subsystem consists of four compartments: descending aorta, systemic arterial bed, systemic venous bed, and systemic large veins. The pulmonary subsystem consists of proximal pulmonary arteries, pulmonary arterial bed, and pulmonary venous bed.

Each compartment (depicted as a block in Fig. 2) in the model was assumed to have a constant compliance (C), where C = partial V(t)/partial P(t), where P(t) is the instantaneous local pressure and V(t) is the instantaneous compartmental blood volume. Law of mass conservation was applied to each compartment and, with adoption of the above definition for C, can be expressed as
<LIM><OP>∑</OP></LIM> <A><AC>Q</AC><AC>˙</AC></A><SUB>in</SUB>(<IT>t</IT>)<IT>−</IT><LIM><OP>∑</OP></LIM> <A><AC>Q</AC><AC>˙</AC></A><SUB>out</SUB>(<IT>t</IT>)<IT>=</IT>C<IT> · </IT><FR><NU>dP(<IT>t</IT>)</NU><DE>d<IT>t</IT></DE></FR>
where Sigma Qin(t) and Sigma Qout(t) indicate the respective sum of the instantaneous volumetric flow rates at the inlet and the outlet of the compartment, respectively.

The momentum conservation law for each interconnection (depicted as lines in Fig. 2) between two compartments can be expressed as
&Dgr;P(<IT>t</IT>)<IT>=R · </IT><A><AC>Q</AC><AC>˙</AC></A>(<IT>t</IT>)<IT>+L · </IT><FR><NU>d<A><AC>Q</AC><AC>˙</AC></A>(<IT>t</IT>)</NU><DE>d<IT>t</IT></DE></FR>
where Delta P(t) is the instantaneous pressure difference applied to the line ends, Q(t) is the instantaneous volumetric flow rate, R is the purely viscous resistance, and L is the inertance. Inertial effects were taken into consideration in the large arteries only.

For the interposition shunt, local fluid dynamics are important. Hence, a more comprehensive expression for the momentum conservation law is used
&Dgr;P(<IT>t</IT>)<IT>=R · </IT><A><AC>Q</AC><AC>˙</AC></A>(<IT>t</IT>)<IT>+K · </IT><A><AC>Q</AC><AC>˙</AC></A>(<IT>t</IT>)<SUP><IT>2</IT></SUP><IT>+L · </IT><FR><NU>d<A><AC>Q</AC><AC>˙</AC></A>(<IT>t</IT>)</NU><DE>d<IT>t</IT></DE></FR>
where K is a constant. The term K · Q(t)2 accounts for the nonlinear effects of convective energy loss due to flow separations, eddies, vortexes, and turbulence associated with flow. Previously, we showed that inertial effects in the shunt are negligible (9). Inasmuch as shunt parameters R and K can be expressed also as functions of the shunt diameter (D) (9, 29), the previous equation can be rewritten as
&Dgr;P(<IT>t</IT>)<IT>=</IT><FR><NU><IT>k<SUB>1</SUB></IT></NU><DE><IT>D<SUP>4</SUP></IT></DE></FR> <A><AC>Q</AC><AC>˙</AC></A>(<IT>t</IT>)<IT>+</IT><FR><NU><IT>k<SUB>2</SUB></IT></NU><DE><IT>D<SUP>4</SUP></IT></DE></FR> <A><AC>Q</AC><AC>˙</AC></A>(<IT>t</IT>)<SUP><IT>2</IT></SUP>
where k1 and k2 are proportionality constants, which can be derived experimentally or computationally; k1 is dependent on shunt length and blood viscosity, and k2 depends on local geometry (shunt angle of insertion, length, and subclavian and pulmonary arterial diameters). Figure 3 reports R and K as functions of D obtained by steady-state computational simulations. Best fitting of the computational data points generated k1 of 960 mmHg · (l/min)-1 · mm4 and k2 of 960 and 5,200 mmHg · (l · min)-2 · mm4 (9).


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 3.   Results from finite-element method (FEM) simulations for fluid dynamics in the systemic-to-pulmonary shunt and interpolated curves for determination of proportionality constants k1 [960 mmHg · (l/min)-1 · mm4] and k2 [5,200 mmHg · (l/min)-2 · mm4].

Combined with equations describing the heart system, applications of the mass and momentum conservation laws generated a set of nonlinear algebraic differential equations that was solved using a Runge-Kutta algorithm of the fourth order with an adaptive step.

Clinical Data

Cardiac catheterization and angiographic data of 28 Norwood patients were available for this study. Some of these data were used as input parameters; other data were used for validation of the model (Table 1). Twenty patients received a 3.5-mm shunt; a 4-mm shunt was used in the remaining eight patients. Table 1 summarizes the anatomic and hemodynamic data.

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Clinical data obtained from catheterization exam

Parameter Values

The parameter values of the shunt have been described above; those of the single ventricle (passive and active pressure relationships) were obtained from previous studies of univentricular circulation (14, 15, 20, 23). No data were available on the pressure-volume relationship of the atria or on the flow resistance across an atrioventricular valve or an ASD in neonatal univentricular heart. Those parameters were extracted from a published model of the fetal heart at full term (17) after appropriate rescaling (13). They are listed in Table 2. Heart rate (HR) and duration of the cardiac cycle (Tc = 1/HR) were derived from our clinical data set. Duration of ventricular systole (Ts,SV = 0.16 + 0.3Tc) increases linearly with duration of the cycle (1), and duration (Ts,LA Ts,RA = 0.3Tc) and time advance (Delta T = 0.02Tc) of atrial systole were calculated as fractions of Tc (24).

                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Values of the parameters describing the heart

The parameter values of the remaining compartments of the circulation were extrapolated from our previous data of hydraulic lumped-parameter models of the fetal and neonatal circulation (12, 14, 15). They were scaled down (13) for an infant with a body surface area of 0.33 m2 (average surface area of our clinical subjects). Total pulmonary and systemic vascular resistances (PVR and SVR, respectively) were obtained from clinical data, and their values were distributed among the model compartments in analogy with the models of the human circulation in the literature (8, 24, 28). Table 3 lists these values.

                              
View this table:
[in this window]
[in a new window]
 
Table 3.   Values of the circulatory parameters adopted for the model with indexed SVR = 21.6 mmHg · m2 · l-1 · min and indexed PVR = 2.3 mmHg · m2 · l-1 · min

O2 Calculations

The O2 transport model had the following unknown variables: O2 contents (ml/dl blood) of the systemic arteries (Cart), of the systemic veins (Cven), and of the pulmonary veins (CPV). Because of the systemic-to-pulmonary shunt, O2 content in the pulmonary arteries was equal to Cart. The first two governing equations were
<A><AC>Q</AC><AC>˙</AC></A><SUB>S</SUB> · C<SUB>ven</SUB><IT>+</IT><A><AC>Q</AC><AC>˙</AC></A><SUB>P</SUB> · C<SUB>PV</SUB><IT>=</IT>CO · C<SUB>art</SUB>

<A><AC>Q</AC><AC>˙</AC></A><SUB>S</SUB><IT> · </IT>(C<SUB>art</SUB><IT>−</IT>C<SUB>ven</SUB>)<IT>=</IT>C<A><AC>V</AC><AC>˙</AC></A><SC>o</SC><SUB>2</SUB>
where QP and QS are pulmonary and systemic mean blood volumetric flow rates, respectively, CO is cardiac output (CO = QP QS), and CVO2 is the whole body O2 consumption. Volumetric flow rates were obtained from the lumped-parameter model of the newborn circulation.

A third equation was derived from the lung O2 exchange model, based on the work by Hill et al. (7). This represented effects of the capillaries in the pulmonary bed as a single unit with volume (Vtot) of 3.5 ml. Hence, variation of the partial pressure of O2 (PO2) with distance along the capillary bed was equivalent to the change of PO2 in an element of blood moving with time
<FR><NU>dP<SC>o</SC><SUB>2</SUB></NU><DE>d<IT>t</IT></DE></FR><IT>=</IT><FR><NU><IT>D</IT><SUB>m</SUB><IT> · </IT>(P<SC>a</SC><SUB>O<SUB>2</SUB></SUB><IT>−</IT>P<SC>o</SC><SUB>2</SUB>)</NU><DE><IT>&agr;+</IT>O<SUB>2</SUB>Cap · slope</DE></FR>
where Dm is the alveolar membrane O2 diffusion capacity (2 ml · min-1 · mmHg-1), PAO2 is the alveolar PO2 (100 mmHg), alpha  is the O2 solubility in blood (0.03 × 10-3 ml · ml-1 · mmHg-1), and O2Cap was the maximal O2 carrying capacity [in ml/dl blood; O2Cap = 1.34 · Hb, where Hb is the Hb content (in g/dl)]. Slope was the slope of the oxyhemoglobin saturation (Sat) curve, described as a function of PO2
Sat<IT>=100 · </IT><FR><NU><IT>a · </IT>P<SC>o</SC><SUP><IT>n</IT></SUP><SUB><IT>2</IT></SUB></NU><DE><IT>1+a · </IT>P<SC>o</SC><SUP><IT>n</IT></SUP><SUB><IT>2</IT></SUB></DE></FR>
where constants a and n were equal to 3 ×10-4 and 2.7, respectively, being PO2 expressed in mmHg (22). O2 content was proportional to Sat by the factor O2Cap.

PO2 and pulmonary venous O2 saturation were obtained by integrating the above differential equation throughout the transit time interval, calculated as the ratio of Vtot to Qp. The integration was carried out under the condition that
Sat<SUB>PV</SUB><IT>−</IT>Sat<SUB>art</SUB><IT>=</IT><FR><NU>U<A><AC>V</AC><AC>˙</AC></A><SC>o</SC><SUB>2</SUB></NU><DE><A><AC>Q</AC><AC>˙</AC></A><SUB>P</SUB><IT> · </IT>O<SUB>2</SUB>Cap</DE></FR>
where UVO2 is the known O2 uptake in the lung, which is assumed to be equal to CVO2.

Systemic O2 delivery (in ml/min) and O2 balance were then calculated as
O<SUB>2</SUB> delivery<IT>=</IT>C<SUB>art</SUB><IT> · </IT><A><AC>Q</AC><AC>˙</AC></A><SUB>S</SUB>

O<SUB>2</SUB> balance<IT>=</IT>O<SUB>2</SUB> delivery/C<A><AC>V</AC><AC>˙</AC></A><SC>o</SC><SUB>2</SUB>
The following assumptions, based on clinical observations (Table 1), are made in the O2 calculations: Hb = 16.52 g/dl and CVO2 = 159.64 ml · min-1 · m-2.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The mathematical model generated flow and pressure temporal tracings, as well as mean values of saturations and O2 delivery.

Validity of the Model

The mathematical model was validated by comparing the results of simulations with a part of the averaged (Table 1) and individual clinical data. The clinical parameters averaged from 28 patients, used as input of the model, were as follows: HR = 125.6 beats/min, indexed PVR (PVRa) = 2.3 mmHg · m2 · l-1 · min, indexed SVR (SVRa) = 21.6 mmHg · m2 · l-1 · min, and D = 3.5 mm. With those input parameters, the simulation showed a CO of 2.22 l/min with a cardiac index (CI) of 6.73 l · min-1 · m-2, QP/QS of 1.14, pulmonary flow of 1.18 l/min, and mean systemic and pulmonary arterial pressures of 69 and 12 mmHg, respectively. Calculated O2 delivery was 546.9 ml · min-1 · m-2, and arterial and venous O2 saturations were 79% and 55.9%, respectively.

Ventricular pressure-volume loops, temporal relationships of ventricular, aortic, and pulmonary arterial pressures, and flow in shunt and aorta are depicted on Fig. 4. The end-diastolic and systolic volumes were 34.9 and 16.9 cm3, respectively, with an ejection fraction of 51.6%.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 4.   Temporal curves for ventricular, aortic, and pulmonary pressures (B), aortic flow (C), and shunt flow (D) and pressure-volume loop (A). Indexed pulmonary and systemic vascular resistance (PVRa and SVRa) = 2.3 and 21.6 mmHg · m2 · l-1 · min, respectively, heart rate (HR) = 120 beats/min, shunt diameter = 3.5 mm.

There was a good correlation between the simulation and the averaged clinical data (Table 1) as well as published data (20, 23).

If one takes individual cases, however, whereas good correlations were obtained in some, there were discrepancies among others. Table 4 shows the ranges of predicted values for various parameters and the percent differences from the observed data. For these simulations, the measured pulmonary venous saturation for each patient was used.

                              
View this table:
[in this window]
[in a new window]
 
Table 4.   Predicted vs. observed data

Effects of Shunt Size

With the use of D as the independent variable, shunt hemodynamics were simulated for diameters of 3, 3.5, 4, 4.5, and 5 mm. Figure 5A demonstrates the result of the simulations where CI and QP/QS are reported as functions of shunt diameter. Enlarging the shunt diameter was associated with increases in CI and QP/QS, resulting in higher pulmonary flow. Augmentation in CI led to increased arterial O2 saturation (Fig. 5B), but not venous O2 saturation. On the other hand, O2 delivery (Fig. 5C) slightly increased when shunt diameter increased from 3 to 3.5 mm and sharply decreased for larger shunts as more blood is diverted to the pulmonary circulation at the expense of the systemic output. Effects of shunt size on mean pulmonary arterial pressure were nearly linear, inasmuch as varying the shunt size from 3 to 5 mm resulted in a pressure increase from 9 to 18 mmHg. Conversely, mean systemic arterial pressure decreased from 81 to 59 mmHg. As expected, the pressure gradient along the shunt decreased as shunt diameter was enlarged, ranging from 72 to 41 mmHg for shunt diameter of 3-5 mm.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 5.   Effects of shunt diameter on cardiac index (CI; A) and pulmonary-to-systemic flow ratio (QP/QS), arterial and venous saturations (Satart and Satven) (B), and O2 delivery (C). PVRa and SVRa = 2.3 and 21.6 mmHg · m2 · l-1 · min, HR = 120 beats/min. Shunt size is associated with increases in CI and QP/QS, resulting in higher pulmonary flow. Augmentation in CI led to an increase in arterial, but not venous, O2 saturation.

Effects of Vascular Resistances

Figure 6 shows CI, QP/QS, arterial and venous saturations, and O2 delivery as functions of PVRa (0.5-20 mmHg · m2 · l-1 · min) for shunt diameter of 3.5 mm and SVRa of 21.6 mmHg · m2 · l-1 · min. CI slightly decreased (from 7.0 to 5.9 l · min-1 · m-2), while QP/QS diminished from 1.23 to 0.64 (Fig. 6A). Arterial and venous saturations showed a similar decline (Fig. 6B), but O2 delivery reached a maximum at PVRa of ~4-5 mmHg · m2 · l-1 · min (Fig. 6C). Mean systemic arterial pressure remained nearly constant (73-79 mmHg), while mean pulmonary arterial pressure showed abrupt elevation with higher PVRa (from 5.5 to 48 mmHg).


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 6.   Effects of PVRa on CI and QP/QS (A), changes in saturations (B), and O2 delivery (C). Shaded areas represent the range of values of our patient population. SVRa = 21.6 mmHg · m2 · l-1 · min, HR = 120 beats/min, shunt diameter = 3.5 mm. CI slightly decreases, while QP/QS decreases. Arterial and venous saturations show a similar decline, but O2 delivery reaches a maximum at PVRa ~ 4-5 mmHg · m2 · l-1 · min.

Figure 7 depicts the effects of SVRa (4-64 mmHg · m2 · l-1 · min) when PVRa was kept constant at 2.3 mmHg · m2 · l-1 · min. Small increments in SVRa resulted in a large drop in CI and near-linear increases in QP/QS as flow became preferentially pulmonary (Fig. 7A). Arterial O2 saturation (Fig. 7B) increased steeply to reach an asymptote near 80% when SVRa reached 20 mmHg · m2 · l-1 · min. Venous O2 saturation behaved differently, however. At low SVRa, venous O2 saturation increased until a peak of 62% was reached at 8 mmHg · m2 · l-1 · min; then a progressive decrease was observed. O2 delivery to the body decreased as SVRa increased (Fig. 7C). Mean pulmonary arterial pressure did not show significant variations (10-12 mmHg), while mean systemic arterial pressure increased from 39 to 82 mmHg.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 7.   Effects of SVRa on CI and QP/QS (A), arterial and venous saturations (B), and O2 delivery (C). Shaded areas represent the range of values of our patient population. PVRa = 2.3 mmHg · m2 · l-1 · min, HR = 120 beats/min, shunt diameter = 3.5 mm. Small increments in SVRa result in a large drop in CI and near-linear increases in QP/QS as flow becomes preferentially pulmonary. Arterial O2 saturation increases steeply to reach an asymptote near 80%. Venous O2 saturation increases until it reaches a peak and then progressively decreases.

Effects of HR

Figure 8 illustrates the effects of increasing HR on CI, QP/QS, arterial and venous O2 saturations, and O2 delivery. CI increased with HR, while QP/QS remained relatively unchanged (Fig. 8A). Arterial and venous O2 saturations increased with respect to HR (Fig. 8B). An increase in HR from 60 to 180 beats/min produced an increase in O2 delivery from 380 to 650 ml O2 · min-1 · m-2 (Fig. 8C).


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 8.   Effects of HR on CI and QP/QS (A), arterial and venous saturations (B), and O2 delivery (C). PVRa and SVRa = 2.3 and 21.6 mmHg · m2 · l-1 · min, respectively, and shunt diameter = 3.5 mm. CI increases with HR, while QP/QS remains relatively unchanged. Arterial and venous O2 saturations, as well as O2 delivery, increase with respect to HR.

Elevated pressure gradients along the shunt were also observed with higher HR, ranging from 45 to 70 mmHg.

Simulation of Early Postoperative Period

In the early postoperative period, PVRa and HR are often increased by inotropic drugs. To evaluate this condition, simulations with PVRa twice the baseline value (4.6 mmHg · m2 · l-1 · min) and HR of 150 beats/min were performed with various shunt diameters (3-5 mm). CI and QP/QS were lower than the baseline values (PVRa = 2.3 mmHg · m2 · l-1 · min and HR = 120 beats/min at rest). This difference was accentuated for larger shunts (Fig. 9, A and B). O2 balance remained almost unchanged (Fig. 9C).


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 9.   CI (A), QP/QS (B), and O2 balance as (C) functions of shunt diameter for 3 physiological conditions: rest, exercise, and immediate postoperative period (early postop). Rest condition was simulated with HR = 120 beats/min, PVRa and SVRa = 2.3 and 21.6 mmHg · m2 · l-1 · min, respectively, and whole body O2 consumption = 159.6 ml · min-1 · m-2. Early postoperative condition was simulated by increasing HR to 150 beats/min and PVRa to 4.6 mmHg · m2 · l-1 · min. SVRa and whole body O2 consumption were unchanged. Exercise was simulated by increasing HR to 180 beats/min and whole body O2 consumption to 319.2 ml · min-1 · m-2, decreasing SVRa to 10.8 mmHg · m2 · l-1 · min, and leaving PVRa at 2.3 mmHg · m2 · l-1 · min.

Simulation of Exercise

Dynamic exercise is characterized by a marked increase in O2 consumption, reduction in SVRa, and elevation in HR (5, 6). We simulated this condition by increasing HR to 180 beats/min, reducing SVRa by one-half (10.8 mmHg · m2 · l-1 · min), and assuming a CVO2 that is twice that at rest.

As expected, CI increased and QP/QS decreased (Fig. 9, A and B). Mean pulmonary arterial pressure increased from 9 to 17 mmHg for respective shunt diameters of 3 and 5 mm. O2 balance as a function of shunt diameter is shown in Fig. 9C. Whereas a 3.5-mm shunt provided a balance >3.5 at rest, O2 balance during exercise was always lower, despite use of larger shunts. Nevertheless, O2 balance during exercise remained >1.5 and increased with larger shunts. It is possible that a combination of highly intensive exercise (i.e., higher CVO2) and small shunts (3 or 3.5 mm) could lead to O2 deficit.

Figure 9 demonstrates that when O2 balance was plotted against QP/QS, the maximum level was reached at QP/QS ~ 1 for all three simulated physiological conditions. Similarly, O2 delivery was at a maximum at QP/QS = 1 in all ranges of PVRa (Fig. 6) and shunt sizes (Fig. 5) simulated in our study.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

This study confirms the clinical experience that the shunt is crucial in the regulation of pulmonary and systemic blood flow and, consequently, of tissue oxygenation.

Shunts of 3.5 mm diameter are most commonly used in neonates. Simulations of the early postoperative state confirm that a 3.5-mm shunt allows for a flow distribution between the systemic and the pulmonary circulations that provides a maximum level of O2 delivery. In the simulation of exercise, however, a 3.5-mm shunt did not provide enough O2 to achieve an optimal O2 balance. Whereas larger shunts would meet these increased O2 requirements during exercise, they would result in a reduction of O2 delivery at rest because of excessive pulmonary flow and reduced systemic flow.

Inasmuch as demand on shunt performance varies with changes in physiological conditions, one limitation of the Norwood operation is the inability of the shunt to satisfy all these conditions. Similarly, the nature of the shunt does not provide for adjustments for growth.

The optimal O2 delivery is achieved when balanced pulmonary and systemic perfusion is established, namely, when QP/QS ~ 1. This is true regardless of shunt size, physiological state, or absolute values of PVR. In other words, when pulmonary and systemic perfusions are equal, the Norwood circulation is optimized.

In practice, despite the fixed nature of the shunt, when O2 requirements change, manipulation of the PVR and SVR is used to maintain the optimal flow ratio. This was confirmed by the introduction in the lumped-parameter model of changes in SVR and PVR similar to those produced by therapeutic manipulation, such as changes in inspired PO2, positive end-expiratory pressure, nitric oxide inhalation, and supplemental CO2 (10, 16-18).

The importance of monitoring venous O2 saturation as an indicator of tissue O2 delivery in the postoperative period has been previously reported (19) and confirmed by our simulations. In all situations, there was a better correlation between venous O2 saturations and O2 delivery than between arterial saturations and O2 delivery. However, the measurement of mixed venous saturation in clinical practice remains difficult (21).

Limitations of the Mathematical Model

CVO2 was kept constant when the effect of HR was simulated. As far as the exercise physiology is concerned, the calculations of O2 delivery and saturations were based on an O2 consumption that was twice the baseline value. The effect of respiration on cardiopulmonary performance was not examined. However, the Frank-Starling mechanism was implemented. Other active regulatory mechanisms were not considered in the present model.

The discrepancies between the calculated and clinical values are most likely related to the deficiencies of the latter. They result from a wide range of anatomic variations, such as anastomotic strictures, kinking, and intimal thickening, of the shunt. These will result in an overestimation of QP/QS, which was our most common error. In addition, flow calculations in clinical practice are based on the measurement of mixed venous saturations (i.e., a mixture of inferior and superior vena cava blood in the right atrium). This value is not available in the Norwood patients, who have an obligatory left-to-right shunt at atrial level (all the pulmonary venous blood mixes with the systemic venous blood in the right atrium to reach the single ventricle). Minor changes in O2 saturations can lead to major differences in QP/QS and, thus, the deficiencies of some of these clinical data.

Finally, the mathematical model presented was not compared with specific patient cases to include a comprehensive validation of all possible clinical scenarios. In addition to the impractical aspects of manipulating physiological parameters in extremely ill children, the ethical implications of such maneuvers in the clinical setting prevented us from acquiring the necessary data. As a consequence, the model in its present form may be useful for some, but not all, patients to whom it is applied. Application of this model is further limited by the inability to predict a priori in which patients the model does not provide good correlation. However, this modeling methodology represents an important new paradigm in the analytic and numerical applications in clinical cardiopulmonary physiology. As such, it remains useful in the understanding and prediction of hemodynamic changes in these patients after their surgical reconstruction.

Conclusions

With the use of the lumped-parameter model of the Norwood circulation, the following points were demonstrated or confirmed.

With increasing shunt size a greater proportion of the CO is directed into the lungs, and this can lead to systemic hypoperfusion and poor O2 delivery.

Changes in SVR have a more dramatic influence on hemodynamics than changes in PVR.

Levels of oxygenation were mostly unchanged by HR. However, extremely low HRs resulted in lower O2 saturations.

There is a better correlation of mixed venous O2 saturation with systemic O2 delivery than of arterial saturation with O2 delivery.

QP/QS = 1 results in optimal O2 balance and O2 delivery in all physiological states and shunt sizes.


    ACKNOWLEDGEMENTS

This work was supported by the British Heart Foundation.


    FOOTNOTES

Address for reprint requests and other correspondence: F. Migliavacca, Dipartimento di Bioingegneria, Politecnico di Milano, Piazza Leonardo da Vinci, 32, 20133 Milan, Italy (E-mail: Migliavacca{at}biomed.polimi.it).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 13 September 1999; accepted in final form 29 November 2000.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Avanzolini, G, Barbini P, Cappello A, and Cevese A. Time-varying mechanical properties of the left ventricle. A computer simulation. IEEE Trans Biomed Eng 32: 756-763, 1985[Web of Science][Medline].

2.   Bellotti, M, Pennati G, Pardi G, and Fumero R. Dilatation of the ductus venosus in human fetuses: ultrasonographic evidence and mathematical modeling. Am J Physiol Heart Circ Physiol 275: H1759-H1767, 1998[Abstract/Free Full Text].

3.   Bove, EL. Current status of staged reconstruction for hypoplastic left heart syndrome. Pediatr Cardiol 19: 308-315, 1998[Web of Science][Medline].

4.   Bove, EL, and Lloyd TR. Staged reconstruction for hypoplastic left heart syndrome. Ann Surg 224: 387-395, 1996[Web of Science][Medline].

5.   Braden, DS, and Carroll JF. Normative cardiovascular response to exercise in children. Pediatr Cardiol 20: 4-10, 1999[Web of Science][Medline].

6.   Braden, DS, and Strong WB. Cardiovascular responses to exercise in childhood. Am J Dis Child 144: 1255-1260, 1990[Abstract/Free Full Text].

7.   Hill, EP, Power GG, and Longo LD. Kinetics of O2 and CO2 Exchange. New York: Dekker, 1989, p. 459-515. (Lung Biol. Health Dis. Ser.)

8.   Li, CW, and Cheng HD. A nonlinear fluid model for pulmonary blood circulation. J Biomech 26: 653-664, 1993[Web of Science][Medline].

9.   Migliavacca, F, Dubini G, Pennati G, Pietrabissa R, Fumero R, Hsia TY, and de Leval MR. Pressure-flow relationship in systemic-to-pulmonary shunts evaluated by means of 3-D steady and pulsatile computational models. J Biomech 33: 549-557, 2000[Web of Science][Medline].

10.   Mora, GA, Pizarro C, Jacobs ML, and Norwood WI. Experimental model of single ventricle. Influence of carbon dioxide on pulmonary vascular dynamics. Circulation 90: II-43-II-46, 1994.

11.   Norwood, WI. Hypoplastic left heart syndrome. Ann Thorac Surg 52: 688-695, 1991[Abstract].

12.   Pennati, G, Bellotti M, and Fumero R. Mathematical modelling of the human fetal cardiovascular system based on Doppler ultrasound data. Med Eng Phys 19: 327-335, 1997[Web of Science][Medline].

13.   Pennati, G, and Fumero R. Scaling approach to study the changes through the gestation of human fetal cardiac and circulatory behaviors. Ann Biomed Eng 28: 442-452, 2000[Web of Science][Medline].

14.   Pennati, G, Migliavacca F, Dubini G, Pietrabissa R, and de Leval MR. A mathematical model of circulation in the presence of the bidirectional cavopulmonary anastomosis in children with a univentricular heart. Med Eng Phys 19: 223-234, 1997[Web of Science][Medline].

15.   Pennati, G, Migliavacca F, Dubini G, Pietrabissa R, Fumero R, and de Leval MR. Use of computational fluid dynamic model to predict hemodynamics in cavopulmonary anastomosis with persistent forward flow. J Surg Res 89: 43-52, 2000[Web of Science][Medline].

16.   Raensbæk, F, Hansen SB, Austin EH, and Santamore WP. Effects of positive pressure ventilation and inspired oxygen on pulmonary vascular resistance and tissue oxygen delivery in neonatal pigs. Cardiol Young 8: 71-78, 1998[Web of Science][Medline].

17.   Reddy, VM, Liddicoat JR, Fineman JR, McElhinney DB, Klein JR, and Hanley FL. Fetal model of single ventricle physiology: hemodynamic effects of oxygen, nitric oxide, carbon dioxide, and hypoxia in the early postnatal period. J Thorac Cardiovasc Surg 112: 437-449, 1996[Abstract/Free Full Text].

18.   Riordan, CJ, Raensbæk F, Storey JH, Montgomery WD, Santamore WP, and Austin EH. Effects of oxygen, positive end-expiratory pressure, and carbon dioxide on oxygen delivery in an animal model of the univentricular heart. J Thorac Cardiovasc Surg 112: 644-654, 1996[Abstract/Free Full Text].

19.   Rossi, AF, Sommer RJ, Lotvin A, Gross RP, Steinberg LG, Kipel G, Golinko RJ, and Griepp RB. Usefulness of intermittent monitoring of mixed venous oxygen saturation after stage I palliation for hypoplastic left heart syndrome. Am J Cardiol 63: 1118-1123, 1994.

20.   Sano, T, Ogawa M, Yabuuchi H, Matsuda H, Nakano S, Shimazaki Y, Taniguchi K, Arisawa J, Hirose H, and Kawashima Y. Quantitative cineangiographic analysis of ventricular volume and mass in patients with single ventricle: relation to ventricular morphologies. Circulation 77: 62-69, 1988[Abstract/Free Full Text].

21.   Scheinman, MM, Brown MA, and Rapaport E. Critical assessment of use of central venous oxygen saturation as a mirror of mixed venous oxygen in severely ill cardiac patients. Circulation 40: 165-172, 1969[Abstract/Free Full Text].

22.   Sharan, M, Singh MP, and Aminataei A. A mathematical model for the computation of the oxygen dissociation curve in human blood. Biosystems 22: 249-260, 1989[Web of Science][Medline].

23.   Shimazaki, Y, Kawashima Y, Mori T, Kitamura S, Matsuda H, and Yokota K. Ventricular volume characteristics of single ventricle before corrective surgery. Am J Cardiol 45: 806-810, 1980[Web of Science][Medline].

24.   Snyder, MF, and Rideout VC. Computer simulation of the venous circulation. IEEE Trans Biomed Eng 16: 325-334, 1969[Medline].

25.   Suga, H. Theoretical analysis of a left ventricular pumping model based on the systolic time-varying pressure-volume ratio. IEEE Trans Biomed Eng 18: 47-55, 1971[Medline].

26.   Suga, H, and Sagawa K. Instantaneous pressure-volume relationships and their ratio in the excised, supported canine left ventricle. Circ Res 35: 117-126, 1974[Abstract/Free Full Text].

27.   Timmons, WD. Cardiovascular models and controls. In: Handbook of Bioengineering, edited by Bronzino JC.. Boca Raton, FL: CRC, 1995, p. 2386-2403.

28.   Ursino, M. Interaction between carotid baroregulation and the pulsating heart: a mathematical model. Am J Physiol Heart Circ Physiol 275: H1733-H1747, 1998[Abstract/Free Full Text].

29.   Young, DF, and Tsai FY. Flow characteristics in models of arterial stenosis. I. Steady flow. J Biomech 6: 395-410, 1973[Web of Science][Medline].


Am J Physiol Heart Circ Physiol 280(5):H2076-H2086
0363-6135/01 $5.00 Copyright © 2001 the American Physiological Society



This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
T.-Y. Hsia, F. Migliavacca, G. Pennati, R. Balossino, G. Dubini, M. R. de Leval, S. M. Bradley, and E. L. Bove
Management of a stenotic right ventricle-pulmonary artery shunt early after the Norwood procedure.
Ann. Thorac. Surg., September 1, 2009; 88(3): 830 - 837.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. S. Sundareswaran, K. Pekkan, L. P. Dasi, K. Whitehead, S. Sharma, K. R. Kanter, M. A. Fogel, and A. P. Yoganathan
The total cavopulmonary connection resistance: a significant impact on single ventricle hemodynamics at rest and exercise
Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2427 - H2435.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. L. Bove, F. Migliavacca, M. R. de Leval, R. Balossino, G. Pennati, T. R. Lloyd, S. Khambadkone, T.-Y. Hsia, and G. Dubini
Use of mathematic modeling to compare and predict hemodynamic effects of the modified Blalock-Taussig and right ventricle-pulmonary artery shunts for hypoplastic left heart syndrome.
J. Thorac. Cardiovasc. Surg., August 1, 2008; 136(2): 312 - 320.e2.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Li, G. Zhang, B. W. McCrindle, H. Holtby, T. Humpl, S. Cai, C. A. Caldarone, A. N. Redington, and G. S. Van Arsdell
Profiles of hemodynamics and oxygen transport derived by using continuous measured oxygen consumption after the Norwood procedure
J. Thorac. Cardiovasc. Surg., February 1, 2007; 133(2): 441 - 448.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
B. Alsoufi, J. Bennetts, S. Verma, and C. A. Caldarone
New Developments in the Treatment of Hypoplastic Left Heart Syndrome
Pediatrics, January 1, 2007; 119(1): 109 - 117.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Ricci, P. Lombardi, A. Galindo, S. Schultz, A. Vasquez, and E. Rosenkranz
Effects of single-ventricle physiology with aortopulmonary shunt on regional myocardial blood flow in a piglet model.
J. Thorac. Cardiovasc. Surg., August 1, 2006; 132(2): 252 - 259.e2.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Li, G. Zhang, H. M. Holtby, B. W. McCrindle, S. Cai, T. Humpl, C. A. Caldarone, W. G. Williams, A. N. Redington, and G. S. Van Arsdell
Inclusion of oxygen consumption improves the accuracy of arterial and venous oxygen saturation interpretation after the Norwood procedure
J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1099 - 1107.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
J. Photiadis, N. Sinzobahamvya, C. Fink, M. Schneider, E. Schindler, A. M. Brecher, A. E. Urban, and B. Asfour
Optimal pulmonary to systemic blood flow ratio for best hemodynamic status and outcome early after Norwood operation.
Eur. J. Cardiothorac. Surg., April 1, 2006; 29(4): 551 - 556.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. F. Corno, M. Prosi, P. Fridez, P. Zunino, A. Quarteroni, and L. K. von Segesser
The non-circular shape of FloWatch(R)-PAB prevents the need for pulmonary artery reconstruction after banding.: Computational fluid dynamics and clinical correlations
Eur. J. Cardiothorac. Surg., January 1, 2006; 29(1): 93 - 99.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Karamlou, D. A. Ashburn, C. A. Caldarone, E. H. Blackstone, R. A. Jonas, M. L. Jacobs, W. G. Williams, R. M. Ungerleider, B. W. McCrindle, and for the Members of the Congenital Heart Surgeons'
Matching procedure to morphology improves outcomes in neonates with tricuspid atresia
J. Thorac. Cardiovasc. Surg., December 1, 2005; 130(6): 1503 - 1510.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
J. Photiadis, M. Hubler, N. Sinzobahamvya, S. Ovroutski, B. Stiller, R. Hetzer, A. E. Urban, and B. Asfour
Does size matter? Larger Blalock-Taussig shunt in the modified Norwood operation correlates with better hemodynamics
Eur. J. Cardiothorac. Surg., July 1, 2005; 28(1): 56 - 60.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
J. Photiadis, A. E. Urban, N. Sinzobahamvya, C. Fink, E. Schindler, M. Schneider, A. M. Brecher, and B. Asfour
Restrictive left atrial outflow adversely affects outcome after the modified Norwood procedure
Eur. J. Cardiothorac. Surg., June 1, 2005; 27(6): 962 - 967.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Arts, T. Delhaas, P. Bovendeerd, X. Verbeek, and F. W. Prinzen
Adaptation to mechanical load determines shape and properties of heart and circulation: the CircAdapt model
Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1943 - H1954.
[Abstract] [Full Text] [PDF]


Home page
Crit Care NurseHome page
D. Soetenga and K. A. Mussatto
Management of Infants With Hypoplastic Left Heart Syndrome: Integrating Research Into Nursing Practice
Crit. Care Nurse, December 1, 2004; 24(6): 46 - 66.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. M. Hoffman, J. S. Tweddell, N. S. Ghanayem, K. A. Mussatto, E. A. Stuth, R. D. B. Jaquis, and S. Berger
Alteration of the critical arteriovenous oxygen saturation relationship by sustained afterload reduction after the norwood procedure
J. Thorac. Cardiovasc. Surg., March 1, 2004; 127(3): 738 - 745.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. M. Bradley, A. M. Atz, and J. M. Simsic
Redefining the impact of oxygen and hyperventilation after the Norwood procedure
J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 473 - 480.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. E. Wright, D. C. Crowley, J. R. Charpie, R. G. Ohye, E. L. Bove, and T. J. Kulik
High systemic vascular resistance and sudden cardiovascular collapse in recovering norwood patients
Ann. Thorac. Surg., January 1, 2004; 77(1): 48 - 52.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. M. Pearl
Right ventricular-pulmonary artery connection in stage 1 palliation of hypoplastic left heart syndrome
J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1268 - 1270.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. N. Fenton, R. D. Siewers, B. Rebovich, and F. A. Pigula
Interim mortality in infants with systemic-to-pulmonary artery shunts
Ann. Thorac. Surg., July 1, 2003; 76(1): 152 - 156.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
E. Malec, K. Januszewska, J. Kolcz, and T. Mroczek
Right ventricle-to-pulmonary artery shunt versus modified Blalock-Taussig shunt in the Norwood procedure for hypoplastic left heart syndrome - influence on early and late haemodynamic status
Eur. J. Cardiothorac. Surg., May 1, 2003; 23(5): 728 - 734.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (31)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Migliavacca, F.
Right arrow Articles by de Leval, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Migliavacca, F.
Right arrow Articles by de Leval, M. R.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online